In the clinical trials behind the US losartan label, fewer people stopped treatment because of side effects on the drug than on placebo: 2.3% versus 3.7%.[1] That is not the profile of a medicine known for causing trouble, and it frames the whole question of losartan hair loss. Alopecia is not in the US label text I could read, it is listed as “uncommon” in some UK product information and absent from other UK versions, and published evidence is close to nonexistent.[1][2][3] What remains is a plausibility question that timing and pattern can help answer, which is what this page walks through.
Medical note: This article is for general education and does not provide personal medical advice. Do not stop or change losartan without clinician guidance. If you are not sure whether you are seeing shedding or breakage, start here: Shedding vs Breakage. If the diagnosis is unclear, start here: How Hair Loss Is Diagnosed. If you have scalp pain/burning, pustules/crusting, heavy scale, open sores, facial swelling, or rapid worsening, start here: When to See a Doctor.
Key points
- The label picture is mixed and weak. I found no mention of alopecia in the US losartan (Cozaar) label text or in the US losartan/hydrochlorothiazide label. A UK losartan/hydrochlorothiazide product lists alopecia as “uncommon,” while a UK losartan-only SmPC does not list it.[1][2][3][9]
- Overall tolerability is good. In US hypertension trials the overall rate of adverse events was similar to placebo, and the events seen more often than placebo included dizziness, upper respiratory infection, nasal congestion and back pain, not hair loss.[1]
- I found no published losartan alopecia case reports or studies. The dermatology sources checked do not discuss ARBs as telogen effluvium (TE) culprits.[4][7]
- TE timing is delayed. Shedding is usually noticed 2 to 4 months after a trigger, and the British Association of Dermatologists (BAD) says around 3 months.[5][6]
- Do not self-stop. If timing fits, the next step is a prescriber-guided review, not abrupt discontinuation.
- Related on this site: ARB Hair Loss: Risk & Timeline • Medication-Related Shedding • Telogen Effluvium • ACE Inhibitor Hair Loss: Risk & Timeline • Beta-Blocker Hair Loss: Risk, Timeline & Fixes.
Quick navigation
- Key points
- What the product information says (and doesn’t)
- Timeline: onset, shedding phase, recovery
- Pattern clues: TE vs AGA vs AA vs breakage
- When labs matter
- What to do
- When to see a doctor
- FAQ
- References
What the product information says (and doesn’t)
US labeling
- Tolerability: the label says treatment with losartan was well tolerated, with an overall incidence of adverse events similar to placebo. Discontinuation for adverse events occurred in 2.3% of losartan patients versus 3.7% of placebo patients.[1]
- What was more common than placebo: among events occurring in at least 2% of losartan patients and more often than placebo, the label lists dizziness (3% vs 2%), upper respiratory infection (8% vs 7%), nasal congestion (2% vs 1%) and back pain (2% vs 1%).[1]
- Alopecia: I could not find alopecia or hair loss anywhere in the losartan label as published on Drugs.com (revised 1/2022), including the post-marketing section, nor in the losartan/hydrochlorothiazide (Hyzaar) label.[1][9] Other label versions exist, so check the version you take.
UK product information
- The losartan potassium 50 mg SmPC (revised March 2025) lists urticaria, pruritus, rash and photosensitivity under skin reactions, with no alopecia.[2]
- A losartan/hydrochlorothiazide SmPC (revised January 2025) lists alopecia under its losartan reactions as “uncommon” (at least 1 in 1,000 but fewer than 1 in 100), together with dermatitis, dry skin, erythema, flushing, photosensitivity, pruritus, rash, urticaria and sweating. Its hydrochlorothiazide list has no alopecia.[3]
Outside the labels
DermNet’s drug list for TE names beta-blockers and ACE inhibitors among antihypertensives; it does not name ARBs.[4] The 2024 Cutis review of medication-induced TE lists ARBs only among first-line blood pressure drugs and does not discuss them as a cause of hair loss.[7] That leaves a plausibility question rather than a documented effect.
What none of this gives you: a reliable percentage, or any difference by sex, age or dose (25, 50 or 100 mg). I found no source that quantifies those, so this page does not guess. Practically, the useful questions are whether the timeline fits TE, whether the pattern is diffuse, and whether there were other triggers in the same window.
Timeline: onset, shedding phase, recovery
- Onset: the key clue is delay. DermNet says hair fall is noticed 2 to 4 months after the trigger; BAD says it can occur around 3 months after.[5][6]
- Shedding phase: BAD gives 3 to 6 months, and calls TE chronic if it lasts more than 6 months.[6]
- Recovery: DermNet says hair fall tapers back to normal over 6 to 9 months in most cases, and BAD says it may take many months for hair to return to normal volume and thickness.[5][6]
- If a drug is the cause and is stopped under medical advice: DermNet says shedding settles within up to 6 months, with regrowth visible within 3 to 6 months and cosmetic recovery sometimes taking 12 to 18 months.[4]
This delay is why the connection is often missed: someone starts losartan, feels fine for weeks, and only later notices more hair in the shower or on the pillow. The same window also fits illness, surgery, weight change or stress.
Pattern clues: TE vs AGA vs AA vs breakage
Most consistent with TE
Medication-linked TE usually looks like diffuse shedding with a generally normal-looking scalp: more hair fall all over, not one sharply defined bald patch.
TE + androgenetic alopecia overlap
If shedding improves but the part line keeps widening or the crown continues to thin, think about overlap with telogen effluvium vs androgenetic alopecia.
Alopecia areata is a different pattern
If you have patchy, smooth, well-defined bald areas, that is less typical for medication-triggered TE and should raise the question of alopecia areata.
Breakage is not the same as shedding
If you mostly see short snapped hairs, rough texture or frayed ends, that points more toward hair breakage than true root-level shedding.
If the scalp is inflamed, think broader than TE
TE is typically non-scarring and without obvious inflammation. If the scalp is very itchy, red, painful or crusted, a simple TE explanation is incomplete; see Itchy Scalp and Hair Loss.
When labs matter
Not everyone with a plausible medication timeline needs a broad lab panel. DermNet lists at least a blood count, iron studies and thyroid function tests when the cause is unclear, and BAD mentions blood tests to exclude conditions such as thyroid problems and iron deficiency.[4][6] They matter most when shedding is heavy, persistent or recurrent, or the history suggests iron deficiency, thyroid disease, major weight change, illness or dietary restriction in the same window.
For the site workup roadmap, use: Blood Tests & Workup.
What to do (practical plan)
- Build the timeline: write down the losartan start date, any dose changes, and the month shedding became noticeable.
- Confirm the pattern: diffuse shedding vs breakage vs overlapping pattern hair loss vs patchy loss.
- Review stacked triggers: illness, fever, surgery, postpartum timing, dieting, weight loss, thyroid issues, low iron, or major stress in the same 2 to 4 month window. DermNet suggests looking back over the three months before the hair loss began.[4]
- Check the exact formulation: losartan alone versus a combination with hydrochlorothiazide or another drug, because combination products complicate attribution and have different labels.[3]
- Talk to the prescriber: if the timing fits, discuss whether to wait and watch or consider an alternative, weighing the cardiovascular benefit. Do not self-stop.
- Avoid supplement roulette: BAD advises supplements only if your diet is restricted, and notes that medication does not speed up TE regrowth.[6]
- Track monthly: photos every 4 weeks in the same lighting and angle, to judge the trend rather than day-to-day anxiety.
Stress is a common co-trigger; see Hair Loss After Stress.
When to see a doctor
- Scalp pain, burning, pustules, open sores, or heavy scale/crusting
- Patchy smooth bald spots rather than diffuse shedding
- Obvious eyebrow or eyelash involvement
- Facial swelling or other possible medication-reaction symptoms: seek urgent care
- Shedding that persists beyond about 6 months or returns in repeated waves
- Unclear diagnosis or rapid worsening
Start here: When to See a Doctor.
FAQ
Does losartan cause hair loss?
It is possible but unproven. Alopecia is absent from the US label text I read and from the UK losartan-only SmPC, listed as “uncommon” in a UK losartan/hydrochlorothiazide SmPC, and I found no published case reports or studies.[1][2][3] If you are shedding, other causes deserve at least equal attention.
Is it more likely in women or men, or at 25, 50 or 100 mg?
No source I found reports losartan-related hair loss by sex, age or dose, so no honest answer can be given. Dose is a blood pressure decision; do not lower it on your own to see whether your hair improves.
Does the label prove losartan caused my shedding?
No. A label entry, where one exists, only shows that a reaction was reported. Causation depends on timing, pattern and whether other triggers were present.
Has anyone’s hair grown back after switching to losartan?
One published case describes a 53-year-old man whose new alopecia on lisinopril (an ACE inhibitor) resolved within 4 weeks after he was switched to losartan.[8] That is a single case and says nothing about how often it happens; see our lisinopril page. Any switch should be decided with your prescriber.
I take losartan with hydrochlorothiazide, bendroflumethiazide or felodipine. Which one is responsible?
The labels alone cannot tell you. The UK losartan/hydrochlorothiazide SmPC lists alopecia under its losartan reactions and not under hydrochlorothiazide, and the US labels I read list it for neither.[1][3][9] I did not verify bendroflumethiazide or felodipine labels. See our pages on hydrochlorothiazide and felodipine, and bring all start dates to the prescriber rather than removing one drug to test it.
Should I stop losartan if I suspect shedding?
No, not on your own. The US label notes no apparent rebound effect after abrupt withdrawal, but that does not make it safe to go without treatment for high blood pressure.[1] Review the timeline and treatment context with the prescriber first.
Why does shedding start months later?
Because TE is delayed: the trigger shifts more hairs into the resting phase first, and the increased shedding becomes noticeable once those hairs are pushed out, typically 2 to 4 months later.[5]
Is losartan hair loss permanent?
When the pattern behaves like TE, it is non-scarring and generally reversible once the trigger resolves, but recovery is slow: DermNet says tapering over 6 to 9 months in most cases, with cosmetic recovery sometimes taking 12 to 18 months after a causative drug is stopped.[4][5]
Can losartan cause body-hair loss on the legs, curly hair, or help hair grow?
I found no source linking losartan to leg-hair loss, to a change in hair texture such as curliness, or to improved hair growth. Neither the labels nor the dermatology sources I checked describe losartan as a hair-loss treatment.
References (trusted sources)
- Drugs.com: Losartan potassium prescribing information (US label revised 1/2022) — tolerability and trial adverse events
- UK electronic medicines compendium: Losartan potassium 50 mg film-coated tablets SmPC
- UK electronic medicines compendium: Losartan potassium/hydrochlorothiazide 100 mg/12.5 mg SmPC — alopecia listed as uncommon under losartan
- DermNet NZ: Alopecia from drugs
- DermNet NZ: Telogen effluvium (hair fall noticed 2–4 months after trigger)
- British Association of Dermatologists (Skin Health Info): Telogen effluvium (around 3 months after a trigger)
- Cutis (2024): Culprits of medication-induced telogen effluvium, part 2
- PubMed: Lisinopril-Induced Alopecia: A Case Report (J Pharm Pract 2017;30(5):562–566)
- Drugs.com: Hyzaar (losartan potassium/hydrochlorothiazide) prescribing information